NASDAQ:CYRX - CryoPort Stock Price, Forecast & News

CryoPort trades on the NASDAQ under the ticker symbol "CYRX."

CryoPort Inc (NASDAQ:CYRX) released its earnings results on Thursday, November, 7th. The consumer goods maker reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.02. The consumer goods maker earned $9.58 million during the quarter, compared to analysts' expectations of $9.49 million. CryoPort had a negative return on equity of 26.50% and a negative net margin of 64.63%. The firm's revenue was up 81.1% on a year-over-year basis. During the same quarter last year, the firm posted ($0.07) earnings per share. View CryoPort's Earnings History.

CryoPort is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for CryoPort.

4 brokerages have issued 12 month target prices for CryoPort's stock. Their forecasts range from $22.00 to $26.00. On average, they anticipate CryoPort's share price to reach $24.00 in the next year. This suggests a possible upside of 63.4% from the stock's current price. View Analyst Price Targets for CryoPort.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CryoPort in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CryoPort.

Media stories about CYRX stock have been trending extremely negative on Thursday, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CryoPort earned a media sentiment score of -4.0 on InfoTrie's scale. They also gave press coverage about the consumer goods maker a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an impact on the company's share price in the next several days. View News Stories for CryoPort.

CryoPort saw a decrease in short interest in the month of October. As of October 15th, there was short interest totalling 6,220,000 shares, a decrease of 13.6% from the September 15th total of 7,200,000 shares. Based on an average daily volume of 660,200 shares, the short-interest ratio is presently 9.4 days. Currently, 17.7% of the shares of the stock are sold short. View CryoPort's Current Options Chain.

Some companies that are related to CryoPort include Forward Air (FWRD), Hub Group (HUBG), Echo Global Logistics (ECHO), Roadrunner Transportation Systems (RRTS) and Sino-Global Shipping America (SINO).

Based on aggregate information from My MarketBeat watchlists, some companies that other CryoPort investors own include Gilead Sciences (GILD), ACADIA Pharmaceuticals (ACAD), Exelixis (EXEL), bluebird bio (BLUE), Global Blood Therapeutics (GBT), Micron Technology (MU), Amgen (AMGN), Huron Consulting Group (HURN), Neurocrine Biosciences (NBIX) and Vertex Pharmaceuticals (VRTX).

CryoPort's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Chevy Chase Trust Holdings Inc. (4.61%), TimesSquare Capital Management LLC (3.78%), State Street Corp (2.61%), Columbus Circle Investors (0.99%), Creative Planning (0.97%) and Granahan Investment Management Inc. MA (0.93%). Company insiders that own CryoPort stock include Jerrell Shelton, Richard J Berman and Robert Stefanovich. View Institutional Ownership Trends for CryoPort.

CYRX stock was sold by a variety of institutional investors in the last quarter, including Creative Planning, Millennium Management LLC, Perkins Capital Management Inc., Taylor Frigon Capital Management LLC, Essex Investment Management Co. LLC, D.A. Davidson & CO., Rice Hall James & Associates LLC and Taylor Wealth Management Partners. Company insiders that have sold CryoPort company stock in the last year include Richard J Berman and Robert Stefanovich. View Insider Buying and Selling for CryoPort.

CYRX stock was acquired by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Chevy Chase Trust Holdings Inc., Columbus Circle Investors, State Street Corp, SG Capital Management LLC, Granahan Investment Management Inc. MA, Castleark Management LLC and SG Americas Securities LLC. View Insider Buying and Selling for CryoPort.

Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CYRX stock can currently be purchased for approximately $14.69.

CryoPort has a market capitalization of $526.55 million and generates $19.63 million in revenue each year. The consumer goods maker earns $-9,560,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. View Additional Information About CryoPort.

The official website for CryoPort is http://www.cryoport.com/.

CryoPort's mailing address is 17305 DAIMLER STREET, IRVINE CA, 92614. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]